LL37 (Human cathelicidin)

LL37 (Human cathelicidin, Ropocamptide) is a cathelicidin-related antimicrobial peptide with potent chemotactic and immunomodulatory properties.

Amino-acid Sequence

LL37 (Human cathelicidin) Amino-acid Sequence

CAS No. 154947-66-7

Selleck's LL37 (Human cathelicidin) has been cited by 2 publications

Purity & Quality Control

Batch: Purity: 99.94%
99.94

Chemical Information & Solubility

Storage (From the date of receipt) 3 years -20°C powder

In vitro
Batch:

Water : 100 mg/mL


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Biological Activity

Description LL37 (Human cathelicidin, Ropocamptide) is a cathelicidin-related antimicrobial peptide with potent chemotactic and immunomodulatory properties.
In vitro
In vitro

LL-37, human is a 37-residue, amphipathic, cathelicidin-derived antimicrobial peptide, which exhibits a broad spectrum of antimicrobial activity. LL-37, human could help protect the cornea from infection and modulates wound healing

Cell Research Cell lines HCECs
Concentrations 1, 2.5, 5, 10 and 20 μg/mL
Incubation Time 24 h
Method

Cells were treated with indicated concentrations of drug for 24 h.

Product Information

Molecular Formula:

C205H340N60O53

Molecular Weight: 4493.26
CAS No.: 154947-66-7
Appearance: White Powder
Peptide Content (by %N): ≥80%
Purity (by HPLC): 0.9862
Single Impurity (by HPLC): ≤1.0%
Assay (By Anhydrous, Acetic Acid-free): 95.0~105.0%
MS: Consistent
Packing: plastic vial(dedicated for peptide packing) or glass vial, quantity according to customer's detail requirement.
Storage
(From the date of receipt):
3 years -20°C powder
Shipping: Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)